Latest Turner syndrome Stories
March 21 is World Down Syndrome Day. The Jérôme Lejeune Foundation, USA is proud to join with disability advocacy associations from 11 nations in an international campaign to say together: Down Syndrome - So What! http://www.downsyndrome-sowhat.eu Philadelphia, PA (PRWEB) March 20, 2013 The Jérôme Lejeune Foundation, USA is proud to join with disability advocacy associations from 11 nations (Spain, Portugal, Croatia, the United-Kingdom, Italy, Germany, Poland, Latvia...
SAN DIEGO, Feb. 4, 2013 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative diagnostic testing and genetic analysis solutions, announced today that the MaterniT21(TM) PLUS laboratory-developed test (LDT) available exclusively through Sequenom Center for Molecular Medicine (Sequenom CMM) will now report as additional findings the presence of certain fetal sex chromosomal aneuploidies, in addition to its identification of autosomal aneuploidies...
REDWOOD CITY, Calif., July 2, 2012 /PRNewswire/ -- Verinata Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that its non-invasive verifi(TM) prenatal test can now be used to detect Turner syndrome (monosomy X or XO), a genetic condition in which a person has one X chromosome and is missing a second sex chromosome. Turner syndrome affects approximately one in every 2,000 female births. (Logo:...
A gene known to be important in cardiac development has been newly associated with congenital heart malformations that result in obstruction of the left ventricular outflow tract. These are the findings from a study conducted by Nationwide Children's Hospital and appearing in the journal Birth Defects Research Part A.Left ventricular outflow tract (LVOT) malformations, including aortic valve stenosis, coarctation of the aorta, hypoplastic left heart syndrome, Shone complex and interrupted...
NEW HAVEN, Conn., March 3, 2011 /PRNewswire/ -- The launch of a new, non-invasive test for the identification of Turner syndrome (TS) was announced today by JS Genetics. The test, XCAT-TS, is a simple cheek swab that identifies girls with Turner syndrome. Until now, Turner syndrome could only be diagnosed with a Karyotype, an invasive test that requires blood from the patient. The results of the XCAT-TS validation study were published in the February 2011 issue of Journal of Clinical...
As a child grows, a short stature is not usually cause for concern, but it is often the only sign of a condition called Turner syndrome. Prevalent in girls, Turner syndrome is a genetic defect that short-circuits normal growth and leads to cardiac and renal problems. It is not commonly detected until age 10 or older when a youngster's unusually short height raises suspicions.This lag before diagnosis of the condition can delay the start of growth hormone therapy, which can help in achieving...
Reproductive Medicine Associates of CT Partners with NJ Affiliate for Award-Winning Clinical Study of Comprehensive Chromosomal Screening Norwalk, CT (PRWEB) January 11, 2011 Reproductive Medicine Associates of Connecticut fertility centers (RMACT) recently participated in a breakthrough study titled "A Prospective Randomized Controlled Trial Demonstrating Significantly Increased Clinical Pregnancy Rates Following 24-Chromosome Aneuploidy Screening: Biopsy and Analysis on Day 5...
A recent study accepted for publication in The Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM) has demonstrated a novel and accurate test for early diagnosis of Turner syndrome. Turner syndrome affects one in 1,500 to 2,000 female live births and early diagnosis allows for the timely management of short stature and co-morbid conditions including cardiac and renal problems.Turner syndrome (TS) is the most common genetic problem affecting girls with short stature....
PRINCETON, N.J., March 3 /PRNewswire/ -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) has approved Norditropin® FlexPro® (somatropin [rDNA origin] injection), a pre-filled injection pen to be used by children and adults with growth hormone disorders. It will be available in the second quarter. To view the multimedia assets associated with this release, please click: http://multivu.prnewswire.com/mnr/novonordisk/42751/ Norditropin® FlexPro® has a...
Metabolic syndrome can increase an individual's healthcare costs by about $2,000 a year, U.S. researchers estimate. Study leader D.M. Boudreau of United BioSource in Bethesda, Md., and colleagues said metabolic syndrome -- including obesity, high blood pressure and elevated fats in the blood -- can place a person at high risk for heart disease. The study also compared the annual healthcare costs for subjects who had both diabetes and metabolic syndrome risk factors and found them to be...
